Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats

Journal of Molecular Medicine

Volumn 75, Issue 5, 1997, Pages 371-377

  Pinto, Yigal M ^a,b   Buikema, Hendrik ^a   Van Gilst, Wiek H ^a   Scholtens, Egbert ^a   Van Geel, Peter Paul ^a   De Graeff, Pieter A ^a   Wagner, Jürgen ^b   Paul, Martin ^b,c,d,e,f  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD UNIVERSITY   (United States)

^f Harvard University ^*

Author keywords

end organ damage; genetic hypertension; renin angiotensin system; SHR transgenics

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM;

EID: 0030981091     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050123     Document Type: Article

References (25)

1. Dahlof B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertension 5:95-110
2. Schiffrin EL, Deng LY (1995) Comparison of the effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 25:699-703
3. Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transsgenic rats harbouring the mouse Ren-2 gene. Nature 44:541-544
4. Lemmer B, Mattes A, Böhm M, Ganten D (1993) Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 22:97-101
5. Buikema H, van Gilst WH, van Veldhuisen DJ, de Smet BJGL, Scholtens E, Lie KI, Wesseling H (1993) Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovasc Res 27:2118-2124
6. Paul M, J Wagner, VJ Dzau (1993) Gene expression of the renin-angiotensin system in human tissues. J Clin Invest 91: 2058-2064
7. Zhao Y, Bader M, Kreutz R, Fernandez-Alfonso M, Zimmerman F, Ganten U, Metzger R, Ganten D (1993) Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR (mRen2)27. Am J Physiol 265:E699-707
8. Pinto YM, de Smet BJGL, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H (1994) Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res 27:1933-1938
9. Schelling P, Ganten U, Sponer G, Unger T, Ganten D (1980) Components of the renin-angiotensin system in the cerbrospinal fluid of rats and dogs with special consideration of the origin and fate of angiotensin II. Neuroendocrinology 31:297-308
10. Lopez-de Leon A, Rojkind M (1985) A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737-743
11. Lee M, Bachmann J, Paul M, Zimmermann F, Ruf P, Bader M, Peters J, Ganten U, Mullins JJ, Ganten D (1997) Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27 carrying the murine ren-2 gene. Am J Physiol (in press)
12. Hilgers KF, Peters J, Sommer M, Rupprecht G, Ganten D, Luft FC, Mann JFE (1992) Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension 19:687-691
13. Yamaguchi, TZ, Tokita Y, Franco-Saenz R, Mulrow PJ, Peters J, Ganten D (1992) Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology 131:1955-1962
14. Villareal FJ, MacKenna DA, Omens JH, Dillman WH (1995) Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension 25:98-104
15. Böhm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M, Erdmann E (1994) Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension 24:653-662
16. Dohi Y, Thiel MA, Bühler FR, Lüscher TF (1990) Activation of endothelial I-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 15:170-179
17. Lee MA, Böhm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D (1995) Differential gene expression of renin and angiotensinogen in the TGR(mRen-2)27 transgenic rat. Hypertension 25:570-580
18. Mullins JJ, Mullins LJ (1994) Transgenes, hypotheses, and hypertension (Editorial). Hypertension 23:428-430
19. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL (1995) Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 25:1014-1020
20. Bachmann S, Peters J, Engler E, Ganten D, Mullins J (1992) Transgenic rats carrying the mouse renin-2 gene: m orphologic characterization of a low-renin hypertension model. Kidney Int 41:24-36
21. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ (1994) Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension 23:422-427
22. Barett G, Ogg D, Peters J, Fleming S, Whitworth C, Mullins J (1994) Hypertension and cardiac hypertrophy as a result of high circulating prorenin levels. J Hypertension 12 [Supp 3]: S172/957 (abstract)
23. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Bohm M, Djavidani B, Peters J, Mullins JJ, Ganten D (1992) Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 19:681-686
24. Djavidani B, Sander M, Böhm M, Zhao Y, Bachmann J, Peters J, Mullins JJ, Ganten D (1992) Dexamethasone suppresses development of hypertension in TGR(mRen)27. J Hypert 10 [Suppl 4]:S10 (abstract)
25. Naftilan AJ, Pratt RJ, Eldridge CS, Lin HL, Dzau VJ (1991) Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 13:706-771